BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23015647)

  • 1. Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis.
    Kassa D; Ran L; Geberemeskel W; Tebeje M; Alemu A; Selase A; Tegbaru B; Franken KL; Friggen AH; van Meijgaarden KE; Ottenhoff TH; Wolday D; Messele T; van Baarle D
    Clin Vaccine Immunol; 2012 Dec; 19(12):1907-15. PubMed ID: 23015647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.
    Black GF; Thiel BA; Ota MO; Parida SK; Adegbola R; Boom WH; Dockrell HM; Franken KL; Friggen AH; Hill PC; Klein MR; Lalor MK; Mayanja H; Schoolnik G; Stanley K; Weldingh K; Kaufmann SH; Walzl G; Ottenhoff TH;
    Clin Vaccine Immunol; 2009 Aug; 16(8):1203-12. PubMed ID: 19553548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients.
    Lee JS; Song CH; Kim CH; Kong SJ; Shon MH; Suhr JW; Jung SS; Lim JH; Kim HJ; Park JK; Paik TH; Jo EK
    Med Microbiol Immunol; 2003 May; 192(2):61-9. PubMed ID: 12736818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.
    Chegou NN; Black GF; Loxton AG; Stanley K; Essone PN; Klein MR; Parida SK; Kaufmann SH; Doherty TM; Friggen AH; Franken KL; Ottenhoff TH; Walzl G
    BMC Infect Dis; 2012 Jan; 12():10. PubMed ID: 22260319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine response to selected MTB antigens in Ghanaian TB patients, before and at 2 weeks of anti-TB therapy is characterized by high expression of IFN-γ and Granzyme B and inter- individual variation.
    Mensah GI; Addo KK; Tetteh JA; Sowah S; Loescher T; Geldmacher C; Jackson-Sillah D
    BMC Infect Dis; 2014 Sep; 14():495. PubMed ID: 25209422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis.
    Al-Attiyah R; Mustafa AS; Abal AT; El-Shamy AS; Dalemans W; Skeiky YA
    Clin Exp Immunol; 2004 Oct; 138(1):139-44. PubMed ID: 15373916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker.
    Borgström E; Andersen P; Atterfelt F; Julander I; Källenius G; Maeurer M; Rosenkrands I; Widfeldt M; Bruchfeld J; Gaines H
    PLoS One; 2012; 7(11):e43438. PubMed ID: 23144772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cytokine profiles related to
    Yasuda I; Saludar NRD; Sayo AR; Suzuki S; Yokoyama A; Ozeki Y; Kobayashi H; Nishiyama A; Matsumoto S; Cox SE; Tanaka T; Yamashita Y
    Front Immunol; 2024; 15():1330796. PubMed ID: 38665909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population.
    Hussain R; Kaleem A; Shahid F; Dojki M; Jamil B; Mehmood H; Dawood G; Dockrell HM
    J Immunol Methods; 2002 Jun; 264(1-2):95-108. PubMed ID: 12191514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report.
    Stern JN; Keskin DB; Romero V; Zuniga J; Encinales L; Li C; Awad C; Yunis EJ
    Immunol Res; 2009; 45(1):1-12. PubMed ID: 18648750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.
    Sutherland JS; Lalor MK; Black GF; Ambrose LR; Loxton AG; Chegou NN; Kassa D; Mihret A; Howe R; Mayanja-Kizza H; Gomez MP; Donkor S; Franken K; Hanekom W; Klein MR; Parida SK; Boom WH; Thiel BA; Crampin AC; Ota M; Walzl G; Ottenhoff TH; Dockrell HM; Kaufmann SH;
    PLoS One; 2013; 8(9):e74080. PubMed ID: 24040170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.
    Belay M; Legesse M; Mihret A; Bekele Y; Ottenhoff TH; Franken KL; Bjune G; Abebe F
    PLoS One; 2015; 10(4):e0124134. PubMed ID: 25897840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.
    Kellar KL; Gehrke J; Weis SE; Mahmutovic-Mayhew A; Davila B; Zajdowicz MJ; Scarborough R; LoBue PA; Lardizabal AA; Daley CL; Reves RR; Bernardo J; Campbell BH; Whitworth WC; Mazurek GH
    PLoS One; 2011; 6(11):e26545. PubMed ID: 22132075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting.
    Abebe F; Belay M; Legesse M; Mihret A; Franken KS
    Clin Exp Immunol; 2017 Aug; 189(2):241-249. PubMed ID: 28374535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.